A service of StreetInsider.com
Ticker Symbol
Welcome

Most Popular

AAPL 493.17
C 33.66
GOOG 611.46
BAC 8.18
RIMM 15.90

Recently Added

CPIC 1.19
SHMX 0.00
NBTH 12.50
COHO 0.00
PZZI 4.71

Gaining Speed

COHO 0.00
SHMX 0.00
CPIC 1.19
NBTH 12.50
AVEW 0.00
2.41 +0.00 (0.00%) PARD

Click Here to Receive Instant E-mail and RSS Alerts


Trade PARD now with

Stock Details

Last Trade:2.41 Change:+0.00 (0.00%) Prev Close:2.41 Open: 1.00 Days Range:2.41 – 2.41 52 Week Range: 0.10 - 3.20 Volume:1000 P/E: N/A
EPS:-12.00





Recent Blog Posts

Blog Posts on 11/21/11 at 3:14am
Trade Ideas From Last Week's Big Biotech News Movers
Blog Posts on 03/06/11 at 8:43am
China Biotech in Review: Thermo Fisher Scientific Displays Increased Commitment
Blog Posts on 11/09/10 at 7:22pm
Poniard Pharmaceuticals CEO Discusses Q3 2010 Results - Earnings Call Transcript
Blog Posts on 08/11/10 at 5:08am
30 Stocks Showing Excessive Pessimism
Blog Posts on 08/09/10 at 6:48pm
Poniard Pharmaceuticals, Inc. Q2 2010 Earnings Call Transcript
Blog Posts on 08/05/10 at 9:53am
24 Stocks and ETFs With Very High Put / Call Ratios
Blog Posts on 05/10/10 at 8:12pm
Poniard Pharmaceuticals, Inc. Q1 2010 Earnings Call Transcript
Blog Posts on 04/04/10 at 4:20am
Biotech Deal Activity Takes a Breather
Blog Posts on 03/24/10 at 4:48pm
Stocks End Lower Amid Portugal Downgrade, Spike in Treasury Yields
Blog Posts on 02/08/10 at 4:14am
GlaxoSmithKline, Poniard, Protalix Provide Biotech's Latest Mishaps
Blog Posts on 01/25/10 at 11:45am
Analyst Upgrades, Downgrades and Initiations: GD, ICE, IGT, SAP, STI, TMH, TSS ...
Blog Posts on 01/22/10 at 5:29pm
Poniard Pharmaceuticals: A Rebound Is Overdue
Blog Posts on 01/11/10 at 4:04am
Poniard Pharmaceuticals: Oversold, Undervalued, Poised for Short Squeeze
Blog Posts on 12/15/09 at 4:08pm
Tuesday Options Recap: Put-Call Ratio Leaders
Blog Posts on 12/07/09 at 10:06am
Options Trader: Monday Market Movement
Blog Posts on 11/25/09 at 4:05am
Azimuth Opportunity Bets on Poniard's Survival
Blog Posts on 11/23/09 at 4:11am
Weak Weekly Market Wrap-Up: Primed for a Correction
Blog Posts on 11/18/09 at 12:58pm
Poniard Pharmaceuticals' Gamble Doesn't Pay Off
Blog Posts on 11/18/09 at 11:45am
Analyst upgrades, downgrades and initiations: FIS, LMNX, RIMM, SII, TGT, TSYS ...
Blog Posts on 11/17/09 at 4:01pm
Tuesday Options Recap
Blog Posts on 11/17/09 at 5:02am
BioMed News Bytes: Cytori, Poniard, Alkermes, Spherix, CRXX, HGSI
Blog Posts on 11/16/09 at 4:16pm
Monday Options Recap
Blog Posts on 10/23/09 at 10:09am
Options Trader Friday Outlook: Churn Baby Churn
Blog Posts on 10/19/09 at 3:58pm
Monday Options Recap
Blog Posts on 09/20/09 at 4:50pm
Spectrum Pharmaceuticals: Despite Share Offering, Still Cheap vs. Other Cancer Drugmakers
Blog Posts on 09/16/09 at 4:03pm
Wednesday's Options Recap
Blog Posts on 09/11/09 at 9:38am
Options Trader Friday Outlook: Up, Up and Away
Blog Posts on 09/11/09 at 5:49am
Spectrum Pharma: Post-Zevalin Approval Sales Should Ramp Up
Blog Posts on 08/23/09 at 9:43am
Biotech Dealmaking Takes a Summer Breather
Blog Posts on 07/31/09 at 3:59pm
Friday Options Recap